Effects_NNS
of_IN
mitogenic_JJ
agents_NNS
upon_IN
glucocorticoid_NN
action_NN
in_IN
human_JJ
tonsillar_JJ
T-lymphocytes_NNS
._.

The_DT
treatment_NN
of_IN
human_JJ
tonsillar_JJ
T-lymphocytes_NNS
with_IN
4-phorbol_NN
12-myristate_NN
13-acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
,_,
resulted_VBD
in_IN
about_RB
two_CD
fold_JJ
increase_NN
in_IN
glucocorticoid_NN
receptor_NN
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
number_NN
,_,
without_IN
any_DT
significant_JJ
change_NN
in_IN
the_DT
receptor_NN
affinity_NN
._.

This_DT
increase_NN
disappeared_VBD
in_IN
the_DT
presence_NN
of_IN
cycloheximide_NN
._.

Alone_RB
,_,
PMA_NN
and_CC
calcium_NN
ionophore_NN
A23187_NN
did_VBD
not_RB
affect_VB
,_,
but_CC
together_RB
stimulated_VBD
,_,
like_IN
phytohaemagglutinin_NN
-LRB-_-LRB-
PHA_NN
-RRB-_-RRB-
,_,
leucine_NN
and_CC
,_,
in_IN
particular_JJ
,_,
thymidine_NN
incorporation_NN
._.

PMA_NN
enhanced_VBD
slightly_RB
the_DT
stimulatory_JJ
effect_NN
of_IN
PHA_NN
._.

Alone_RB
,_,
these_DT
agents_NNS
failed_VBD
to_TO
alter_VB
the_DT
suppressive_JJ
effect_NN
of_IN
dexamethasone_NN
on_IN
thymidine_NN
and_CC
leucine_NN
incorporation_NN
;_:
however_RB
,_,
PMA-A23187_NN
and_CC
PMA-PHA_JJ
combinations_NNS
appeared_VBD
to_TO
antagonize_VB
the_DT
suppression_NN
by_IN
dexamethasone_NN
._.

